Rachael Zimlich, RN
Ms Zimlich is a freelance writer in Cleveland, Ohio. She writes regularly for Contemporary Pediatrics, Managed Healthcare Executive, and Medical Economics.
HIV patients benefit from organized system of physician care
Ronald H. Goldschmidt, MD, discusses when and how primary care physicians should care for patients with HIV.
Unvaccinated adults cost U.S. billions in care, lost productivity
Lead researcher hopes results of new study motivates more adults to improve vaccination compliance.
Duke launches campaign to boost adult vaccination
Duke launches campaign to boost adult vaccination
Researchers and physicians are working together to discover why adults skip recommended vaccines and what doctors can do to increase immunization rates.
Trust is the bedrock of effective communication with HIV patients
Physicians must first establish a trusting relationship with HIV patients who struggle with both physical and social stressors.
Mobile apps offer options for tracking HIV management
Mobile apps offer HIV patients more options for managing their treatments and medications, but whether those apps are improving outcomes has yet to be seen.
Trend to watch: Payer-provider joint ventures
Joint ventures are gaining steam as health plans and providers look for new ways to work together.
Primary care is the best tool for early HIV diagnosis
Primary care physicians may not manage later HIV/AIDS treatment, but they are on the front line for the early detection and diagnosis that could save a life.
HIV management requires team of physicians
As new therapies transform HIV management from acute to chronic, primary care physicians have a greater role in supporting the interventions of specialists.
Researchers zero in on a cure for the common cold
Scientists at Emory University have developed a vaccine they say may work well in preventing infection with rhinovirus—the top cause of the common cold.
Alzheimer’s vaccine targets early and later disease stages
A new vaccine against Alzheimer’s targets two proteins involved in the development of the disease in hopes to offer both early and late protection.

Poll

View Results